20200212 Guidelines comparison tablev10 [online] UPDATED 2020 v4

Independent professional body guideline

Type 2 diabetes pharmacological management pathway comparison

2020-02-14T00:00:00+00:00By Guidelines team

This comparison table summarises recommendations on the management of hyperglycaemia in adults with type 2 diabetes from ADA/EASD, NICE, and SIGN.

Doctor talking to patient in office_AS

Working party guideline/algorithm

Guideline for the managed introduction of biosimilar basal insulin

2019-10-09T15:02:00+01:00By Working party—Down Beba Brown Diggle Goel Milne

This guideline was developed by a multidisciplinary expert panel: Down S et al with the support of a grant from Mylan.

diabetes equipment 640x426

SIGN guideline

SIGN type 2 diabetes guideline

2018-01-16T11:53:00+00:00By

This summary provides key recommendations on lifestyle management, treatment options, diabetic CVD, and CKD. Includes a useful treatment algorithm

Resource hub

  • Blood glucose diaries

Educational resources

Takeda webinar promotion  index image

On demand webinars

Real-world evidence in the management of type 2 diabetes: switching from other DPP‑4 inhibitors to alogliptin (Vipidia®)

Commissioned by Takeda UK Ltd

This promotional educational webinar has been organised and funded by Takeda UK Ltd. See bottom of page for full disclaimer.

Doctor talking to patient in office_AS

Working party guideline/algorithm

Guideline for the managed introduction of biosimilar basal insulin

By Working party—Down Beba Brown Diggle Goel Milne

This guideline was developed by a multidisciplinary expert panel: Down S et al with the support of a grant from Mylan.

Doctors-with-ipad-and-device

Working party guideline/algorithm

Pancreatic exocrine insufficiency guideline

By Development group: Hambling Cummings Merriman & Widdowson

This management algorithm was developed by a multidisciplinary expert panel: Hambling C et al with the support of a grant from Mylan Ltd.